Orchid Pharma Limited has submitted a regulatory disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the Scheme of Amalgamation of Dhanuka Laboratories Limited (the "Amalgamating Company") with Orchid Pharma Limited (the "Amalgamated Company").
The Hon'ble National Company Law Tribunal (NCLT), Chennai, has allowed the petition sanctioning the Scheme of Amalgamation and Arrangement on June 05, 2026. This approval results in the transfer and vesting of Dhanuka Laboratories Limited into Orchid Pharma Limited on a going concern basis. The scheme involves the amalgamation of both companies and their respective shareholders and creditors.
The company will submit the official copy of the NCLT order to the stock exchanges once it becomes available from the tribunal. This disclosure serves as a continuation of previous intimations dated March 18, 2026, regarding the merger petition.